PI-RADS: Where Next?

被引:23
|
作者
Turkbey, Baris [1 ]
Purysko, Andrei S. [2 ]
机构
[1] NCI, Mol Imaging Branch, NIH, 10 Ctr Dr,MSC 1182,Bldg 10,Room B3B85, Bethesda, MD 20892 USA
[2] Cleveland Clin, Sect Abdominal Imaging, Dept Nucl Radiol, Imaging Inst, Cleveland, OH USA
关键词
DIFFUSION-COEFFICIENT VALUES; SYSTEM VERSION 2; PROSTATE-CANCER; MRI; OUTCOMES; IMAGES; RISK; MEN;
D O I
10.1148/radiol.223128
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Prostate MRI plays an important role in the clinical management of localized prostate cancer, mainly assisting in biopsy decisions and guiding biopsy procedures. The Prostate Imaging Reporting and Data System (PI-RADS) has been available to radiologists since 2012, with the most up-to-date and actively used version being PI-RADS version 2.1. This review article discusses the current use of PIRADS, including its limitations and controversies, and summarizes research that aims to improve future iterations of this system.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] Head-to-head comparison of PI-RADS v2 and PI-RADS vl
    Polanec, Stephan
    Helbich, Thomas H.
    Bickel, Hubert
    Pinker-Domenig, Katja
    Georg, Dietmar
    Shariat, Shahrokh F.
    Aulitzky, Wolfgang
    Susani, Martin
    Baltzer, Pascal A.
    EUROPEAN JOURNAL OF RADIOLOGY, 2016, 85 (06) : 1125 - 1131
  • [2] Validation of the PI-RADS language: predictive values of PI-RADS lexicon descriptors for detection of prostate cancer
    Rudolph, Madhuri M.
    Baur, Alexander D. J.
    Haas, Matthias
    Cash, Hannes
    Miller, Kurt
    Mahjoub, Samy
    Hartenstein, Alexander
    Kaufmann, David
    Rotzinger, Roman
    Lee, Chau Hung
    Asbach, Patrick
    Hamm, Bernd
    Penzkofer, Tobias
    EUROPEAN RADIOLOGY, 2020, 30 (08) : 4262 - 4271
  • [3] Follow-up MR imaging of PI-RADS 3 and PI-RADS 4 prostate lesions
    Hauth, Elke
    Jaeger, Horst
    Hohmuth, Horst
    Beer, Meinrad
    CLINICAL IMAGING, 2017, 43 : 64 - 68
  • [4] Improving the understanding of PI-RADS in practice: characters of PI-RADS 4 and 5 lesions with negative biopsy
    Wang, Yu-Hao
    Liang, Chao
    Zhu, Fei-Peng
    Zhou, Tian-Ren
    Li, Jie
    Wang, Zeng-Jun
    Liu, Bian-Jiang
    ASIAN JOURNAL OF ANDROLOGY, 2023, 25 (02) : 217 - 222
  • [5] Validation of the PI-RADS language: predictive values of PI-RADS lexicon descriptors for detection of prostate cancer
    Madhuri M. Rudolph
    Alexander D. J. Baur
    Matthias Haas
    Hannes Cash
    Kurt Miller
    Samy Mahjoub
    Alexander Hartenstein
    David Kaufmann
    Roman Rotzinger
    Chau Hung Lee
    Patrick Asbach
    Bernd Hamm
    Tobias Penzkofer
    European Radiology, 2020, 30 : 4262 - 4271
  • [6] PI-RADS Steering Committee: The PI-RADS Multiparametric MRI and MRI-directed Biopsy Pathway
    Padhani, Anwar R.
    Barentsz, Jelle
    Villeirs, Geert
    Rosenkrantz, Andrew B.
    Margolis, Daniel J.
    Turkbey, Bares
    Thoeny, Harriet C.
    Cornud, Francois
    Haider, Masoom A.
    Macura, Katarzyna F.
    Tempany, Clare M.
    Verma, Sadhna
    Weinreb, Jeffery C.
    RADIOLOGY, 2019, 292 (02) : 464 - 474
  • [7] PI-RADS: Past, present, and future
    Gupta, Rajan T.
    Mehta, Kurren A.
    Turkbey, Baris
    Verma, Sadhna
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2020, 52 (01) : 33 - 53
  • [8] PI-RADS 2.0 for Prostate MRI
    Franiel, T.
    Roethke, M.
    RADIOLOGE, 2017, 57 (08): : 665 - 678
  • [9] PI-RADS: past, present and future
    Richenberg, J. L.
    CLINICAL RADIOLOGY, 2016, 71 (01) : 23 - 24
  • [10] Prostate cancer in PI-RADS scores 1 and 2 version 2.1: a comparison to previous PI-RADS versions
    Bogner, Katja
    Engelhard, Karl
    Wuest, Wolfgang
    Hamel, Sajad
    ABDOMINAL RADIOLOGY, 2022, 47 (06) : 2187 - 2196